Company: BIAF
Filing Date: 2025-10-09
Form Type: 424B5
Source: 0001493152-25-017591
Chunk: 16

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-10-09
Form: 424B5
Chunk 16
---
 of this offering.

The foregoing does not purport to be a complete statement of the terms and conditions of the Placement Agency Agreement and the securities purchase agreements. A copy of the form of securities purchase agreements will be included as an exhibit to our Current Report on Form 8-K to be filed with the SEC and incorporated by reference into the registration statement of which this prospectus supplement and the accompanying prospectus form a part. See “Incorporation of Certain Information By Reference” and “Where You Can Find More Information.”

No action has been or will be taken in any jurisdiction (except in the United States) that would permit a public offering of the securities offered by this prospectus supplement and accompanying prospectus, or the possession, circulation or distribution of this prospectus supplement and accompanying prospectus or any other material relating to us or the securities offered hereby in any jurisdiction where action for that purpose is required. Accordingly, the securities offered hereby may not be offered or sold, directly or indirectly, and neither of this prospectus supplement and accompanying prospectus nor any other offering material or advertisements in connection with the securities offered hereby may be distributed or published, in or from any country or jurisdiction except in compliance with any applicable rules and regulations of any such country or jurisdiction. WallachBeth may arrange to sell securities offered by this prospectus supplement and accompanying prospectus in certain jurisdictions outside the United States, either directly or through affiliates, where they are permitted to do so.

Right of First Refusal

According to the terms of the placement agency agreement, WallachBeth shall have the right of first refusal until January 30, 2026 to participate in each and every future public and private equity and debt offerings of the Company, or any successor to or any subsidiary of the Company.

| S-9 |

Tail Rights

If the Company, within six (6) months after the closing of this offering, effects a sale of any securities with a party brought “over-the-wall” by WallachBeth in connection with this offering, the Company shall pay to WallachBeth the cash discount and warrants set forth above upon the completion of such transaction (to the extent allowable by FINRA).

Other Relationships

From time to time, the WallachBeth may provide in the future various advisory, investment and commercial banking and other services to us in the ordinary course of business, for which they have received and may continue to receive customary fees and commissions. However, except as disclosed in this prospectus, we have no present arrangements with the WallachBeth for any further services